CRYOPORT, INC. Standard and Extended Product Warranty Accrual
CRYOPORT, INC. (CYRX) had Standard and Extended Product Warranty Accrual of $1.10 million as of 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Payables and Accruals
us-gaap:ProductWarrantyAccrual · last filed 2026-03-05
- 2025-12-31: Standard and Extended Product Warranty Accrual $1.10M.
- 2024-12-31: Standard and Extended Product Warranty Accrual $900.00K.
- 2023-12-31: Standard and Extended Product Warranty Accrual $700.00K.
- 2023-03-31: Standard and Extended Product Warranty Accrual $700.00K.
| Period end | Standard and Extended Product Warranty Accrual |
|---|---|
| 2025-12-31 | $1.10M 10-K · filed 2026-03-05 |
| 2024-12-31 | $900.00K 10-K · filed 2026-03-05 |
| 2023-12-31 | $700.00K 10-K · filed 2025-03-07 |
| 2023-03-31 | $700.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $700.00K 10-Q · filed 2023-05-04 |
| 2022-09-30 | $700.00K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $500.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $500.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $500.00K 10-K · filed 2023-02-28 |
| 2021-09-30 | $200.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $200.00K 10-Q · filed 2021-08-06 |
| 2021-03-31 | $200.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $200.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |